COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 1515: Articles 15141-15150  | Next

mRNA vaccine-induced SARS-CoV-2-specific T cells recognize B.1.1.7 and B.1.351 variants but differ in longevity and homing properties depending on prior infection status
Neidleman, J., Luo, X., McGregor, M., Xie, G., Murray, V., Greene, W. C., Lee, S. A., Roan, N. R.
10.1101/2021.05.12.443888 — Posted: 2021-05-12
Energy Landscape of the SARS-CoV-2 Reveals Extensive Conformational Heterogeneity
Mashayekhi, G., Vant, J., Singharoy, A., Ourmazd, A.
10.1101/2021.05.11.443708 — Posted: 2021-05-12
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
Zarkoob, H., Allue-Guardia, A., Chen, Y.-C., Jung, O., Vilanova, A. G., Song, M., Park, J.-G., Oladunni, F., Miller, J., Tung, Y.-T., Kosik, I., Schultz, D., yewdell, j., Torrelles, J. B., Martinez-Sobrido, L., Cherry, S., Ferrer, M., Lee, E. M.
10.1101/2021.05.11.443693 — Posted: 2021-05-12
Neutralization potential of Covishield vaccinated individuals against B.1.617.1
Yadav, P., Sapkal, G. N., Abraham, P., Deshpande, G., Nyayanit, D., Patil, D. Y., Gupta, N., Sahay, R. R., Shete, A., Kumar, S., Panda, S., Bhargava, B.
10.1101/2021.05.12.443645 — Posted: 2021-05-12
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
Sun, S., Cai, Y., Song, T.-Z., Pu, Y., Cheng, L., Xu, H., Meng, C., Lin, Y., Sun, J., Zhang, S., Gao, Y., Han, J.-B., Feng, X.-L., Yu, D.-D., Zhu, Y., Gao, P., Tang, H., Zhao, J., Yang, J., Hu, Z., Zhang, Z., Fu, Y.-X., Zheng, Y.-T., Peng, H.
10.1101/2021.05.12.443228 — Posted: 2021-05-12
Impacts on the structure-function relationship of SARS-CoV-2 spike by B.1.1.7 mutations
Yang, T.-J., Yu, P.-Y., Chang, Y.-C., Liang, K.-H., Tso, H.-C., Ho, M.-R., Chen, W.-Y., Lin, H.-T., Wu, H.-C., Hsu, S.-T. D.
10.1101/2021.05.11.443686 — Posted: 2021-05-12
First description of two immune escape indian B.1.1.420 and B.1.617.1 SARS-CoV2 variants in France
Garcia, V., Vig, V., Peillard, L., Ramdani, A., Mohamed, S., Halfon, P.
10.1101/2021.05.12.443357 — Posted: 2021-05-12
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19
Kaplonek, P., Wang, C., Bartsch, Y., Fischinger, S., Gorman, M. J., Bowman, K., Kang, J., Dayal, D., Martin, P., Nowak, R., Hsieh, C.-L., Feldman, J., Juelg, B., Nilles, E., Musk, E. R., Menon, A. S., Fischer, E. S., McLellan, J. S., Schmidt, A., Goldberg, M. B., Filbin, M., Hacohen, N., Lauffenburger, D. A., Alter, G.
10.1101/2021.05.11.443609 — Posted: 2021-05-12
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Liu, J., Budylowski, P., Samson, R., Griffin, B. D., Babuadze, G., Rathod, B., Colwill, K., Abioye, J. A., Schwartz, J. A., Law, R., Yip, L., Ahn, S. K., Chau, S., Naghibosadat, M., Arita, Y., Hu, Q., Yue, F. Y., Banerjee, A., Mossman, K., Mubareka, S., Kozak, R. A., Pollanen, M. S., Orozco, N. M., Gingras, A.-C., Marcusson, E. G., Ostrowski, M. A.
10.1101/2021.05.11.443286 — Posted: 2021-05-12
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard
Saeed, S., O'Brein, S. F., Abe, K., Yi, Q., Rathod, B., Wang, J., Fazel-Zarandi, M., Tuite, A., Fisman, D., Wood, H., Colwill, K., Gingras, A.-C., Drews, S.
10.1101/2021.05.11.21256992 — Posted: 2021-05-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).